BIO International 2026
Accelerate Development to Commercial Success
Biopharma teams are under pressure to deliver faster, reduce risk and prove value earlier. Syneos Health® brings clinical and commercial together—helping you remove barriers, improve performance and maximize impact at every stage.
Why Meet With Us
From early development through launch and beyond, we deliver integrated solutions designed to accelerate progress and reduce uncertainty:
- End-to-end clinical development that anticipates risk and accelerates timelines
- Embedded, experienced teams that act as an extension of your organization
- Data-driven decision-making powered by predictive modeling and real-time insights
- Real World Evidence (RWE) and market insights to optimize strategy and strengthen positioning
- Seamless transition to commercialization with fully integrated commercial capabilities
From Insight to Impact
Our fully integrated model connects clinical, medical affairs and commercial expertise—so you can:
- Remove bottlenecks and improve trial performance
- Strengthen regulatory alignment and study confidence
- Scale commercialization with agility and precision
- Enable successful, efficient asset launches
Whether you’re an emerging biotech or a global pharma organization, we tailor solutions to meet your needs—helping you navigate complexity and deliver results with confidence.
Let's Connect
Book time with our team to explore how we can accelerate your program and maximize your asset’s potential.
Featured Session
From Breakthroughs to Boardrooms: Women Shaping the New Biopharma Era
June 23 | 4:15pm
Related Content:
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
Capabilities
Introducing Ari™, Pharma’s First AI-Driven Naming Platform
Bring Your Clinical Trial to Australia for Global Reach and Local Experience
End-to-End Expertise in Early-Phase Oncology
Comprehensive Hematology-Oncology Experience
Neuroscience Experience and Expertise
Real World Evidence at Syneos Health
Insights
Investing for Launch Success: What Matters Most (and When)
A “Three-V” Framework for Biopharma Market Expansion
WEBINAR | Unlocking Global Market Expansion Beyond the US
PODCAST | Syneos Health Podcast: Conversations on Commercialization
Mitigating EU Manufacturer Exposure to US MFN Policy
